Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT06630130
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
100 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Stomach Neoplasms
RECRUITING
NCT05376878
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
10 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Anatomic Stage IV Breast Cancer AJCC v8


Metastatic Breast Carcinoma


Metastatic Malignant Neoplasm in the Brain
RECRUITING
NCT06750484
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
40 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer Metastatic
RECRUITING
NCT05945732
DESTINY Breast Respond HER2-(Ultra)Low Europe
2,295 Enrollment(s)
211 Study location(s)
OBSERVATIONAL (None)
Unresectable Breast Cancer


Metastatic Breast Cancer


HER2-low Expressing Breast Cancer


HER2-(Ultra)Low Expressing Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04488822
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
40 Enrollment(s)
9 Study location(s)
INTERVENTIONAL (PHASE3)
Tenosynovial Giant Cell Tumor
RECRUITING
NCT07157852
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
674 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Fibromyalgia


Pregabalin


Mirogabalin


Pain
RECRUITING
NCT05408845
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
146 Enrollment(s)
152 Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Salivary Gland Carcinoma


Recurrent Salivary Gland Carcinoma


Stage III Major Salivary Gland Cancer AJCC v8


Stage IV Major Salivary Gland Cancer AJCC v8


Unresectable Salivary Gland Carcinoma
COMPLETED
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor